Klinikum Frankfurt (Oder) GmbH
Frankfurt (Oder), Germany
General hospital in Frankfurt, Brandenburg
Müllroser Ch 7, 15236 Frankfurt (Oder)
About Klinikum Frankfurt (Oder) GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
5
German CLL Study Group
4
Charite University, Berlin, Germany
3
Biotronik SE & Co. KG
2
Hoffmann-La Roche
2
Technische Universität Dresden
2
Applied Therapeutics, Inc.
1
European Organisation for Research and Treatment of Cancer - EORTC
1
GWT-TUD GmbH
1
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
1
Johannes Gutenberg University Mainz
1
Clinical Trials at Klinikum Frankfurt (Oder) GmbH
During the past decade, Klinikum Frankfurt (Oder) GmbH conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
1999-07-01
Completed
430
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
2005-11-01
2011-03-01
Completed
195
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
2005-10-01
2015-06-01
Completed
825
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
1999-07-01
2007-07-01
Completed
375
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
2005-11-01
2018-08-01
Completed
592
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Frankfurt (Oder) GmbH" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials, followed by "German CLL Study Group" with 4 trials
sponsored, "Charite University, Berlin, Germany" with 3 trials sponsored, "Biotronik SE & Co. KG" with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Frankfurt (Oder) GmbH"
#1 collaborator was "Amgen" with 2 trials as a collaborator, "BARMER" with 2 trials as a collaborator, "German CLL Study Group" with 2 trials as a collaborator, "Technische Universität Berlin" with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at Klinikum Frankfurt (Oder) GmbH
According to Clinical.Site data, the most researched conditions in "Klinikum Frankfurt (Oder) GmbH" are
"Lymphoma" (5 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Multiple Myeloma" (2 trials), "AML" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Klinikum Frankfurt (Oder) GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Frankfurt (Oder) GmbH
Most popular intervention types in "Klinikum Frankfurt (Oder) GmbH" are "Drug" (22 trials), "Biological" (9 trials), "Radiation" (5 trials), "Behavioral" (3 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (5 trials), "prednisone" (5 trials), "vincristine sulfate" (5 trials) and "Rituximab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Frankfurt (Oder) GmbH
The vast majority of trials in "Klinikum Frankfurt (Oder) GmbH" are
30 trials for "All" genders.
Clinical Trials Status at Klinikum Frankfurt (Oder) GmbH
Currently, there are NaN active trials in "Klinikum Frankfurt (Oder) GmbH".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in Klinikum Frankfurt (Oder) GmbH,
1 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Frankfurt (Oder) GmbH, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".